Concurrent opioid and alcohol withdrawal management

Concurrent alcohol and opioid withdrawal syndrome is a common and challenging clinical scenario with little published evidence or guidance to inform pharmacotherapy strategies. Concurrent use of benzodiazepines and opioid agonists, which are considered first-line agents for management of each withdr...

Full description

Bibliographic Details
Main Author: Michelle Colvard, PharmD, BCPP
Format: Article
Language:English
Published: American Association of Psychiatric Pharmacists 2023-12-01
Series:Mental Health Clinician
Subjects:
Online Access:https://theijpt.org/doi/pdf/10.9740/mhc.2023.12.268
_version_ 1797404038260588544
author Michelle Colvard, PharmD, BCPP
author_facet Michelle Colvard, PharmD, BCPP
author_sort Michelle Colvard, PharmD, BCPP
collection DOAJ
description Concurrent alcohol and opioid withdrawal syndrome is a common and challenging clinical scenario with little published evidence or guidance to inform pharmacotherapy strategies. Concurrent use of benzodiazepines and opioid agonists, which are considered first-line agents for management of each withdrawal syndrome independently, is controversial and often avoided in clinical practice. Strategies to provide effective, simultaneous medication treatment of alcohol and opioid withdrawal while optimizing patient safety are demonstrated through 3 patient cases.
first_indexed 2024-03-09T02:48:09Z
format Article
id doaj.art-517a331feab94069a9e0ba64cb7030e9
institution Directory Open Access Journal
issn 2168-9709
language English
last_indexed 2024-03-09T02:48:09Z
publishDate 2023-12-01
publisher American Association of Psychiatric Pharmacists
record_format Article
series Mental Health Clinician
spelling doaj.art-517a331feab94069a9e0ba64cb7030e92023-12-05T15:09:07ZengAmerican Association of Psychiatric PharmacistsMental Health Clinician2168-97092023-12-0113626827510.9740/mhc.2023.12.268i2168-9709-13-6-268Concurrent opioid and alcohol withdrawal managementMichelle Colvard, PharmD, BCPPConcurrent alcohol and opioid withdrawal syndrome is a common and challenging clinical scenario with little published evidence or guidance to inform pharmacotherapy strategies. Concurrent use of benzodiazepines and opioid agonists, which are considered first-line agents for management of each withdrawal syndrome independently, is controversial and often avoided in clinical practice. Strategies to provide effective, simultaneous medication treatment of alcohol and opioid withdrawal while optimizing patient safety are demonstrated through 3 patient cases.https://theijpt.org/doi/pdf/10.9740/mhc.2023.12.268alcohol withdrawalopioid withdrawalbenzodiazepinesmedications for opioid use disordermedications for alcohol use disorder
spellingShingle Michelle Colvard, PharmD, BCPP
Concurrent opioid and alcohol withdrawal management
Mental Health Clinician
alcohol withdrawal
opioid withdrawal
benzodiazepines
medications for opioid use disorder
medications for alcohol use disorder
title Concurrent opioid and alcohol withdrawal management
title_full Concurrent opioid and alcohol withdrawal management
title_fullStr Concurrent opioid and alcohol withdrawal management
title_full_unstemmed Concurrent opioid and alcohol withdrawal management
title_short Concurrent opioid and alcohol withdrawal management
title_sort concurrent opioid and alcohol withdrawal management
topic alcohol withdrawal
opioid withdrawal
benzodiazepines
medications for opioid use disorder
medications for alcohol use disorder
url https://theijpt.org/doi/pdf/10.9740/mhc.2023.12.268
work_keys_str_mv AT michellecolvardpharmdbcpp concurrentopioidandalcoholwithdrawalmanagement